Latest filing published 17 May 2022 for Adverum Biotechnologies, Inc., €8,271.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Rupert D'Souza: trading record in brief
All filings by Rupert D'Souza on record concern Adverum Biotechnologies, Inc., in the capacity of finance chief. We count 2 filings; the first trade dates from 13 May 2022 and the latest from 17 May 2022.
Every open-market trade on record is a purchase: 2 purchases worth €16k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 17 May 2022: an open-market purchase of €7,842, in Adverum Biotechnologies, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rupert D'Souza
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.8585100.0% of flowCommon StockSEC:0001209191-22-029847:0Canonical exit: 11 Aug 2022 (T+90)
1 of 1 declaration